Literature DB >> 30894688

Diversity-disease relationships and shared species analyses for human microbiome-associated diseases.

Zhanshan Sam Ma1,2, Lianwei Li3, Nicholas J Gotelli4.   

Abstract

Diversity indices have been routinely computed in the study of human microbiome-associated diseases (MADs). However, it is still unclear whether there is a consistent diversity-disease relationship (DDR) for the human MADs, and whether there are consistent differences in the taxonomic composition of microbiomes sampled from healthy versus diseased individuals. Here we reanalyzed raw data and used a meta-analysis to compare the microbiome diversity and composition of healthy versus diseased individuals in 41 comparisons extracted from 27 previously published studies of human MADs. In the DDR analysis, the average effect size across studies did not differ from zero for a comparison of healthy versus diseased individuals. In 30 of 41 comparisons (73%) there was no significant difference in microbiome diversity of healthy versus diseased individuals, or of different disease classes. For the species composition analysis (shared species analysis), the effect sizes were significantly different from zero. In 33 of 41 comparisons (80%), there were fewer OTUs (operational taxonomic units) shared between healthy and diseased individuals than expected by chance, but with 49% (20 of 41 comparisons) statistically significant. These results imply that the taxonomic composition of disease-associated microbiomes is often distinct from that of healthy individuals. Because species composition changes with disease state, some microbiome OTUs may serve as potential diagnostic indicators of disease. However, the overall species diversity of human microbiomes is not a reliable indicator of disease.

Entities:  

Mesh:

Year:  2019        PMID: 30894688      PMCID: PMC6775969          DOI: 10.1038/s41396-019-0395-y

Source DB:  PubMed          Journal:  ISME J        ISSN: 1751-7362            Impact factor:   10.302


  7 in total

Review 1.  Vaginal microbiome: rethinking health and disease.

Authors:  Bing Ma; Larry J Forney; Jacques Ravel
Journal:  Annu Rev Microbiol       Date:  2012-06-28       Impact factor: 15.500

2.  A summary five-factor cephalometric analysis based on natural head posture and the true horizontal.

Authors:  M S Cooke; S H Wei
Journal:  Am J Orthod Dentofacial Orthop       Date:  1988-03       Impact factor: 2.650

Review 3.  Frontiers in research on biodiversity and disease.

Authors:  Pieter T J Johnson; Richard S Ostfeld; Felicia Keesing
Journal:  Ecol Lett       Date:  2015-08-10       Impact factor: 9.492

4.  Analyses of the microbial diversity across the human microbiome.

Authors:  Kelvin Li; Monika Bihan; Shibu Yooseph; Barbara A Methé
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

Review 5.  The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease.

Authors:  Robert P Dickson; Gary B Huffnagle
Journal:  PLoS Pathog       Date:  2015-07-09       Impact factor: 6.823

6.  Waste not, want not: why rarefying microbiome data is inadmissible.

Authors:  Paul J McMurdie; Susan Holmes
Journal:  PLoS Comput Biol       Date:  2014-04-03       Impact factor: 4.475

Review 7.  The healthy human microbiome.

Authors:  Jason Lloyd-Price; Galeb Abu-Ali; Curtis Huttenhower
Journal:  Genome Med       Date:  2016-04-27       Impact factor: 11.117

  7 in total
  22 in total

Review 1.  Role of the Microbiome in the Pathogenesis of COVID-19.

Authors:  Rituparna De; Shanta Dutta
Journal:  Front Cell Infect Microbiol       Date:  2022-03-31       Impact factor: 5.293

Review 2.  The Interplay between Androgen and Gut Microbiota: Is There a Microbiota-Gut-Testis Axis.

Authors:  Xiangping Li; Wei Cheng; Haitao Shang; Hong Wei; Chunhua Deng
Journal:  Reprod Sci       Date:  2021-05-26       Impact factor: 3.060

Review 3.  Host microbiota can facilitate pathogen infection.

Authors:  Emily J Stevens; Kieran A Bates; Kayla C King
Journal:  PLoS Pathog       Date:  2021-05-13       Impact factor: 6.823

4.  Critical Network Structures and Medical Ecology Mechanisms Underlying Human Microbiome-Associated Diseases.

Authors:  Zhanshan Sam Ma
Journal:  iScience       Date:  2020-05-23

5.  Assessing and Interpreting the Metagenome Heterogeneity With Power Law.

Authors:  Zhanshan Sam Ma
Journal:  Front Microbiol       Date:  2020-05-06       Impact factor: 5.640

6.  Metagenome-wide association study of gut microbiome revealed novel aetiology of rheumatoid arthritis in the Japanese population.

Authors:  Toshihiro Kishikawa; Yuichi Maeda; Takuro Nii; Daisuke Motooka; Yuki Matsumoto; Masato Matsushita; Hidetoshi Matsuoka; Maiko Yoshimura; Shoji Kawada; Satoru Teshigawara; Eri Oguro; Yasutaka Okita; Keisuke Kawamoto; Shinji Higa; Toru Hirano; Masashi Narazaki; Atsushi Ogata; Yukihiko Saeki; Shota Nakamura; Hidenori Inohara; Atsushi Kumanogoh; Kiyoshi Takeda; Yukinori Okada
Journal:  Ann Rheum Dis       Date:  2019-11-07       Impact factor: 19.103

7.  Testing the Anna Karenina Principle in Human Microbiome-Associated Diseases.

Authors:  Zhanshan Sam Ma
Journal:  iScience       Date:  2020-03-25

Review 8.  Gut microbiota in obesity.

Authors:  Bing-Nan Liu; Xiao-Tong Liu; Zi-Han Liang; Ji-Hui Wang
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

9.  Effects of Psychotropics on the Microbiome in Patients With Depression and Anxiety: Considerations in a Naturalistic Clinical Setting.

Authors:  Yoshihiro Tomizawa; Shunya Kurokawa; Daiki Ishii; Katsuma Miyaho; Chiharu Ishii; Kenji Sanada; Shinji Fukuda; Masaru Mimura; Taishiro Kishimoto
Journal:  Int J Neuropsychopharmacol       Date:  2021-02-15       Impact factor: 5.176

10.  The Microbiota-Gut-Brain Axis in Mental Health and Medication Response: Parsing Directionality and Causality.

Authors:  Thomaz F S Bastiaanssen; John F Cryan
Journal:  Int J Neuropsychopharmacol       Date:  2021-03-17       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.